Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia: Study of the Japan Adult Leukemia Study Group (JALSG)

2007 ◽  
Vol 86 (4) ◽  
pp. 343-347 ◽  
Author(s):  
Shuichi Miyawaki ◽  
Yasukazu Kawai ◽  
Akihiro Takeshita ◽  
Norio Komatsu ◽  
Noriko Usui ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Phase I ◽  
Cytosine Arabinoside ◽  
Myeloid Leukemia ◽  
Phase I Trial ◽  
Study Group ◽  
Refractory Acute Myeloid Leukemia ◽  
High Doses ◽  
Adult Leukemia ◽  
Acute Myeloid

scholarly journals A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E

Haematologica ◽  
2014 ◽  
Vol 100 (1) ◽  
pp. e7-e9 ◽  
Author(s):  
S. Assouline ◽  
B. Culjkovic-Kraljacic ◽  
J. Bergeron ◽  
S. Caplan ◽  
E. Cocolakis ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Phase I ◽  
Myeloid Leukemia ◽  
Phase I Trial ◽  
Low Dose ◽  
Refractory Acute Myeloid Leukemia ◽  
Low Dose Cytarabine ◽  
Acute Myeloid

High-Dose Cytosine-Arabinoside and Mitoxantrone in Refractory Acute Myeloid Leukemia: A Clinical Phase I/II-Study

1986 ◽  
Vol 9 (3) ◽  
pp. 144-146 ◽  
Author(s):  
W. Hiddemann ◽  
H. Kreutzmann ◽  
K. Straif ◽  
W.D. Ludwig ◽  
R. Donhuijsen-Ant ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Phase I ◽  
Cytosine Arabinoside ◽  
Myeloid Leukemia ◽  
High Dose ◽  
Clinical Phase ◽  
Refractory Acute Myeloid Leukemia ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document